Clinical Trials Sponsored by ProgenaCare Global, LLC

Total 46 results

ProgenaCare Global, LLC

Active, not recruiting

Efficacy of ProgenaMatrix™ in the Management of DFUs

Diabetic Foot Ulcer

United States
ProgenaCare Global, LLC
Professional Education and Research Institute

Completed

Evaluating The Efficacy Of A Keratin Graft In Treating Non-Healing Diabetic Foot Ulcers

Diabetic Foot Ulcer | Ulcer Healing

United States
Global Aesthetics LLC

Recruiting

Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation

Wrinkle

United States
Global Genomics Group, LLC

Unknown

GLOBAL Clinical Study (GLOBAL)

Coronary Artery Disease

United Kingdom, United States, Hungary, Netherlands, Australia, Germany, Poland, Canada, Croatia
MaineHealth
Global Blood Resources, LLC

Completed

The Effect of the Hemobag® Ultrafiltration System on Blood Conservation and Coagulation After Cardiopulmonary Bypass

Blood Coagulation Disorders

United States
Retina Global
VisionQuest Biomedical LLC

Completed

The Santa Cruz Diabetic Retinopathy Utilizing Artificial Intelligence Study (SC-DRAI)

Diabetic Retinopathy

Bolivia
University of Washington
WillowWood Global LLC

Completed

Community Walking Trials: Comparing Prosthetic Feet

Lower Extremity Amputation

United States
Global Infusion and Aspiration Systems, LLC

Unknown

Effects of Intensive Bolus Intravenous Insulin Delivery on Metabolic Integrity in Type 1 and Type 2 Diabetes

Diabetes Mellitus | Metabolic Integrity

United States
Amneal Pharmaceuticals, LLC
CBCC Global Research

Recruiting

Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.

Ocular Hypertension | Glaucoma, Open-Angle

United States
ClinLogic LLC
MDGlobal

Recruiting

Strategic Targeting for Optimal Prevention of Cancer (STOP-Cancer)

Early Detection of Cancer

United States
Trinitas Global, LLC
AccessDx Laboratories, Houston, TX

Recruiting

INFLAMmatory BiomarkErs in COVID-19 Participants and Severity of Disease (INFLAME COVID)

COVID-19

United States
Texas A&M University
Anderson Global Group, LLC

Completed

Anderson Study 1 - Tart Cherry Study (AS1)

Health Services Research

United States
Global Isotopes, LLC d/b/a Zevacor Molecular

Completed

Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer

Metastatic Prostate Cancer

United States
Piyavate Hospital
T.C Union Global Plc.

Completed

Effect of Glutathione on Blood Alcohol and Hangover Symptoms

Alcohol Drinking

Thailand
Global Alliance for TB Drug Development
QPS Holdings LLC

Completed

Evaluation of the Safety, Tolerability, PK of TBAJ-587 in Healthy Adults

Tuberculosis

Netherlands
Amneal Pharmaceuticals, LLC
CBCC Global Inc.; Amneal EU, Limited

Not yet recruiting

A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes

Ocular Hypertension | Open-angle Glaucoma

United States
Philips Clinical & Medical Affairs Global
North American Science Associates, LLC

Enrolling by invitation

Tempus Pro Monitor Registry

Sudden Cardiac Arrest | Emergency Care

United States
University of North Carolina, Chapel Hill
Global Dental Science, LLC

Withdrawn

Conventionally vs. Digitally Fabricated Complete Dentures: Clinical Treatment Outcome Differences

Mouth, Edentulous

United States
Janssen Research & Development, LLC
The George Institute for Global Health, Australia

Completed

A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus (CANVAS-R)

Diabetes Mellitus, Type 2 | Albuminuria

Australia, France, Italy, Poland, Ukraine, United Kingdom, United States, China, Belgium, Germany, Taiwan, Spain, Argentina, Mexico, Malaysia, Canada, Netherlands, Korea, Republic of, New Zealand, Brazil, Russian Federation, Puerto... and more
Janssen Research & Development, LLC
The George Institute for Global Health, Australia

Completed

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy (CREDENCE)

Diabetes Mellitus, Type 2 | Diabetic Nephropathy

United States, Canada, France, Germany, Poland, Ukraine, United Kingdom, China, Taiwan, Spain, Argentina, Colombia, Mexico, Bulgaria, India, Malaysia, Romania, Serbia, South Africa, Japan, Australia, Korea, Republic of, Chile, New Zealand and more
Janssen Research & Development, LLC
The George Institute for Global Health, Australia

Completed

CANVAS - CANagliflozin cardioVascular Assessment Study (CANVAS)

Cardiovascular Diseases | Diabetes Mellitus, Type 2 | Risk Factors

United States, Australia, Poland, Ukraine, United Kingdom, Belgium, Germany, France, Spain, Argentina, Colombia, Israel, Mexico, India, Canada, Netherlands, Sweden, Malaysia, New Zealand, Estonia, Russian Federation, Hungary, Norway, ... and more
Astellas Pharma Global Development, Inc.
Cubist Pharmaceuticals LLC

Completed

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects

Healthy Subjects | Pharmacokinetics of Fidaxomicin

United States
Merck Sharp & Dohme LLC
Seagen Inc.; Astellas Pharma Global Development, Inc.

Active, not recruiting

Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Participants Who Are Cisplatin-ineligible or Decline Cisplatin With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)

Urinary Bladder Cancer, Muscle-invasive

Canada, United States, Australia, Belgium, France, Hungary, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Thailand, Ukraine, Argentina, Colombia, Denmark, Germany, Ireland, Israel, Japan, Malaysia, Philippines, Sing... and more
Astellas Pharma Global Development, Inc.
Merck Sharp & Dohme LLC

Recruiting

A Study of ASP1570 Taken by Itself or With Pembrolizumab in Adults With Solid Tumors

Advanced Solid Tumors

United States, Japan
Astellas Pharma Global Development, Inc.
Merck Sharp & Dohme LLC

Completed

A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors

Metastatic Cancer | Advanced Cancer | Solid Tumors

United States
Astellas Pharma Global Development, Inc.
Merck Sharp & Dohme LLC

Completed

A Study of ASP1951 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

United States, Korea, Republic of, Canada, Taiwan
Astellas Pharma Global Development, Inc.
Merck Sharp & Dohme LLC

Completed

A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

United States, Korea, Republic of, Taiwan, Canada, Italy, Japan, Portugal, Spain, United Kingdom
Astellas Pharma Global Development, Inc.
Merck Sharp & Dohme LLC

Completed

A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

United States, Korea, Republic of, Taiwan, Portugal, Spain, United Kingdom, Italy, Canada, Japan
Global Alliance to Immunize Against AIDS Vaccine...
Merck Sharp & Dohme LLC

Completed

STI Knowledge and HPV Vaccine Acceptance in Bamako, Mali in 2012

HPV-Related Cervical Carcinoma | HPV
Global Alliance to Immunize Against AIDS Vaccine...
Merck Sharp & Dohme LLC

Unknown

KAP/WTP and HPV Prevalence Studies in a Developing World Setting (Bamako, Mali) (HPV)

Human Papillomavirus

Mali
Astellas Pharma Global Development, Inc.
Merck Sharp & Dohme LLC; Seagen Inc.

Recruiting

Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer (EV-302)

Urothelial Cancer

United States, Argentina, Australia, Belgium, Canada, China, Czechia, Denmark, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Singapore, Spain, Switzerland, Taiwan, Thailand and more
Astellas Pharma Global Development, Inc.
Merck Sharp & Dohme LLC; Seagen Inc.

Recruiting

A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

Locally Advanced or Metastatic Malignant Solid Tumors

United States, Japan, Canada
Astellas Pharma Global Development, Inc.
Merck Sharp & Dohme LLC; Seagen Inc.

Active, not recruiting

A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer (EV-103)

Urologic Neoplasms | Urinary Bladder Neoplasms | Carcinoma, Transitional Cell | Ureteral Neoplasms | Urothelial Cancer | Urethral Neoplasms | Renal Pelvis Neoplasms

United States, Italy, Spain, Canada, France, Puerto Rico
University of Illinois at Urbana-Champaign
LSVT Global; Apple Inc.; Amazon.com Services LLC; Google LLC.; Microsoft Corporation and other collaborators

Recruiting

Speech Accessibility Project (SAP)

Parkinson Disease | Multiple System Atrophy | Progressive Supranuclear Palsy | Dementia With Lewy Bodies

United States
International Agency for Research on Cancer
University of North Carolina Global Project Zambia; Liger Medical Llc

Completed

Development, Field Testing and Evaluation of the Efficacy of a Hand-held, Portable and Affordable Thermo-coagulator to Prevent Cervical Cancer in Low- and Middle-income Countries (DELTA)

Cervical Precancer

Zambia
Astellas Pharma Global Development, Inc.
Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Active, not recruiting

A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) (ARCHES)

Metastatic Hormone Sensitive Prostate Cancer

Korea, Republic of, Japan, United States, Argentina, Australia, Belgium, Canada, Chile, Denmark, Finland, France, Germany, Israel, Italy, Netherlands, New Zealand, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, United...
Astellas Pharma Global Development, Inc.
Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer

Advanced Breast Cancer | HER2 Amplified | Human Epidermal Growth Factor Receptor 2 (HER2)

United States, Belgium, Canada, Italy, Spain, United Kingdom
Astellas Pharma Global Development, Inc.
Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide (UPWARD)

Metastatic Castration-resistant Prostate Cancer (mCRPC)

France, Germany, Spain, United States, Argentina, Australia, Belgium, Canada, Chile, Czechia, Finland, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Singapore, Sweden, Taiwan, United Kingdom
Astellas Pharma Global Development, Inc.
Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance (ENACT)

Prostate Cancer

United States, Canada
Astellas Pharma Global Development, Inc.
Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients

Metastatic Castration-Resistant Prostate Cancer

United States
Galmed Pharmaceuticals Ltd
Kramer Consulting, LLC; WCCT Global; Diamond Pharma Services Regulatory Affairs... and other collaborators

Completed

Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol Administered Under Fed Conditions in Healthy Chinese Volunteers

Healthy Volunteers

United States
University of Medicine and Dentistry of New Jersey
Global Blood Resources, LLC

Terminated

The Use of HEMOBAG to Salvage Blood After Cardiac Surgery

Cardiopulmonary Bypass | Cardiac Diseases

United States
Pine Trees, Inc.
Piedmont Healthcare; ICON plc; MRI Global; ASCLEPES Research Center; Eastside Research... and other collaborators

Completed

A Clinical Evaluation of Pine Trees Health Test System Including the Pine Trees Health Reader and COVID-19 Test for Point-of-Care

Covid19 | SARS (Severe Acute Respiratory Syndrome)

United States
University of Minnesota
Merck Sharp & Dohme LLC; Astellas Pharma Inc; Medical Research Council; Washington... and other collaborators

Completed

Observational Study of C. Diff in Post-Transplant Patients (CDIFF)

Clostridium Difficile

Spain, United States, Argentina, Denmark, Germany
University of Cambridge
Global Institute for Motorsport Safety (GIMSS) - Year 1; Neurolign Technologies... and other collaborators

Completed

Research Evaluating Sports ConcUssion Events - Rapid Assessment of Concussion and Evidence for Return (RESCUE-RACER)

Concussion, Brain | Motor Vehicle Accident

United Kingdom
Cardiovascular Center Frankfurt
Sheba Medical Center; Kerstin Piayda, CardioVascular Center Frankfurt, Frankfurt... and other collaborators

Active, not recruiting

Therapy Strategies After LAA Occluder Device Embolization (LAAODE)

Risk Factors | Left Atrial Appendage Occluder | Device Embolisation | Therapy Strategies

Germany

Clinical Trials Sponsored by ProgenaCare Global, LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations